Tuesday, 13 May 2014

Mahashwetha



Mahashwetha by Sudha Murty, though deceptively simple in its narrative construction, is in truth a profoundly affecting meditation on beauty, love, societal prejudice, and the indomitable quest for self-worth. Through the quietly luminous journey of one woman’s resilience, Murty interrogates the moral fabric of a world that all too often mistakes superficial appearance for intrinsic value.

Penned originally in Kannada and later translated into English, the novel exemplifies Murty’s quintessential literary signature — a prose of beguiling simplicity concealing deep reservoirs of empathy and moral intelligence. Beneath her unadorned sentences lies an unwavering humanism, a steadfast concern for dignity amidst the vicissitudes of circumstance.

At its centre stands Anupama, a paragon of grace, intellect, and aesthetic allure — a young woman from a modest middle-class background whose poise and promise elevate her above the quotidian mediocrity of her milieu. When she encounters Dr. Anand, an urbane and affluent physician, their union seems divinely ordained — a fairy-tale culmination of charm, intellect, and aspiration. Yet, the idyll soon disintegrates under the corrosive weight of social prejudice and fragile masculinity.

Anupama’s life is upended by the onset of vitiligo, a skin condition that becomes, in the eyes of her conservative society, a grotesque aberration rather than a mere medical affliction. The same community that once lionized her beauty now recoils in horror, and the husband who once adored her metamorphoses into an embodiment of cowardice and moral vacuity. Anand’s retreat — both emotional and physical — epitomizes the hollowness of conditional love and the tyranny of aesthetic obsession.

Banished from the sanctuary of her marital home and stripped of social validation, Anupama endures the crucible of isolation. Yet, from these ashes of humiliation emerges not despair, but defiance. In Bangalore, she reconstructs her life with a quiet tenacity — earning her independence, reclaiming her selfhood, and redefining beauty on her own terms.

Murty’s narrative thereby metamorphoses into a modern parable of feminine fortitude. Anupama’s evolution from a dependent wife to a self-reliant woman is not articulated through rebellion or bombast, but through the dignified assertion of moral and emotional autonomy. When Anand, belatedly enlightened by remorse, seeks reconciliation, Anupama’s refusal to return is not vindictive but redemptive — an act of serene self-respect that transcends the narrow confines of vengeance.

At a deeper level, Mahashwetha indicts the cosmetic superficiality that governs societal attitudes. Murty’s critique of the cult of appearance is not shrill but surgical — exposing how humanity’s fixation on skin and status corrodes compassion and corrodes the moral soul. Anand, in this schema, becomes a symbol of societal frailty — his love evaporating under the first sign of imperfection, his conscience crumbling before the altar of conformity.

Anupama’s acceptance of her condition marks a profound spiritual metamorphosis — a transition from self-pity to self-possession, from the tyranny of mirrors to the sovereignty of the soul. The cliché “beauty is only skin deep” acquires here a gravitas born of lived truth rather than aphoristic convenience.

Murty’s literary aesthetic has always been one of lucid sincerity. She eschews verbal pyrotechnics in favour of crystalline clarity, yet her prose throbs with emotional authenticity. There is no melodramatic contrivance, only the understated poignancy of real human experience. Through secondary characters such as Dr. Vasanth and Sumithra, she underscores her abiding moral credo — that kindness and empathy are the true indices of civilization.

The title Mahashwetha — literally “great whiteness” — is itself a masterstroke of irony and symbolism. It alludes not merely to the protagonist’s affliction, but to her inner radiance, her moral luminosity that eclipses the darkness of societal ignorance. The very “whiteness” that once ostracized her becomes, in time, the insignia of her transcendence.

Ultimately, Mahashwetha is not a tale of disease, but of deliverance; not a lament over lost beauty, but a celebration of self-realization. It is a literary mirror held up to a world obsessed with appearances, urging us to look beyond the epidermal and embrace the essential.

Sudha Murty, with characteristic restraint and moral clarity, gifts us a story that is both particular in its Indian ethos and universal in its emotional truth. Mahashwetha leaves its readers chastened, inspired, and ennobled — a paean to the quiet heroism of those who, like Anupama, discover that the truest light shines not on the skin, but from within. Goodreads 4/5

Picture taken from the internet not with an intention to violation of copyright. 

penal charges on inoperative bank accounts

The RBI has clarified vide its circular dated 6th May, 2014 that banks are not permitted to levy penal charges for non maintenance of minimum balances in any inoperative account. 
Earlier such charges were allowed to be levied on normal savings bank accounts while no charges were to be levied on Basic Savings Bank accounts. On the normal savings bank accounts also the banks could levy penal charges only after informing the customers regarding the same at the time of opening bank accounts. 
But now the penal charges on all inoperative bank accounts has been eliminated. This is a measure towards better customer service by the banks. 
A copy of the RBI circular is to be found here i.e. http://www.rbi.org.in/scripts/NotificationUser.aspx?Id=8867&Mode=0

Saturday, 10 May 2014

Foreclosure charges/ pre-payment penalty banned

RBI has vide its circular dated 7th May 2014 immediately banned the foreclosure charges/ pre-payment penalty that was being levied by banks and financial institutions on pre-payment of loans by borrowers. This will be brought into effect immediately but will cover only loans with floating rate of interest and that too only for individual borrowers. 
Not clear why RBI has left our the fixed interest rate borrowers and commercial entities who borrow monies. 
It is a case of too little, too late from RBI. 
RBI should levy a fine of a few thousand crores on all the banks and financial institutions who have been levying these charges on borrowers for all these years and reimburse to the borrowers who have been so effected. 
The copy of the circular can be found here. 

Re-schedulement of ECBs - simplification of procedure

RBI has vide its circular dated simplified its procedure for re-schedulement of External Commercial Borrowings. The re-schedulement will now be allowed subject to the following conditions:
  1. Changes, if any, in all-in-cost (AIC) is only on account of the change in average maturity period (AMP) due to re-schedulement of ECB and post re-schedulement, the AIC and the AMP are in conformity with applicable guidelines. There should not be any increase in the rate of interest and no additional cost (in foreign currency / Indian Rupees) should be involved.
  2. The re-schedulement is allowed only once, before the maturity of the ECB.
  3. If the lender is an overseas branch of a domestic bank, the prudential norms applicable on account of re-schedulement should be complied with.
  4. The changes on account of re-schedulement should be reported to DSIM through revised Form 83.
  5. The ECB should be in compliance with all applicable guidelines related to eligible borrower, recognised lender, AIC, AMP, end-uses, etc.
  6. The borrower should not be in the default / caution list of RBI and should not be under the investigation of Directorate of Enforcement.
The re-schedulement facility will be available both on automatic and approval route ECBs. The copy of the RBI circular can be found here.
http://www.rbi.org.in/scripts/NotificationUser.aspx?Id=8870&Mode=0 

Friday, 9 May 2014

FDI in pharma sector

RBI has clarified vide its circular dated 21st April, 2014 that in case of FDI in the pharma sector, “non compete clause” would not be allowed in the agreements except in special circumstances and that too only with the approval of the Foreign Investment Promotion Board. FDI is allowed in pharma sector upto 100% in greenfield investments under the automatic route and 10% in brownfield investments (i.e. investments in existing companies) with the government approval. 
The relevant RBI circular can be accessed here. 

A Man Alone

This post is written in Aari, a  South Omotic language, spoken in the North Omo zone of the Southern Nations, Nationalities, and Peoples...